Salama Marwa Ahmed Mohamed, Mostafa Nahed E, Abd El-Aal Naglaa Fathy, Moawad Howayda Said Fouad, Hammad Samar Kamel, Adel Rasha, Mostafa Eman M
Department of Medical Parasitology, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
Department of Pharmacognosy, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt.
J Parasit Dis. 2022 Mar;46(1):24-36. doi: 10.1007/s12639-021-01412-y. Epub 2021 Jun 19.
Trichinellosis is a re-emerging zoonotic disease that has become a public health concern since its reported human outbreaks in many countries. The traditional therapy has many adverse effects in addition to the developing resistance. So, this necessitates finding effective natural alternatives. The current study targeted to assess the potential therapeutic effects of and in comparison to albendazole, a conventional therapy for treatment of trichinosis Sixty mice were classified into five groups (12 mice each), non-infected control, infected control, combined albendazole and prednisolone, , and treated groups. Mice sacrifice was performed on the 7th and 35th days post infection for intestinal and muscular phases respectively. Efficiency of the used preparations was assessed by parasitological, histopathological, immunohistochemical, biochemical studies in addition to ultrastructural evaluation using transmission electron microscopy. A significant reduction in the mean number of adult worms and larvae was observed in and treated groups, (64.5%, 50.8%) and (68%, 54.6%) respectively. Also, both extracts showed moderate cytoplasmic reactivity for TGF-β1, (69.3% & 67.8%) respectively. The highest reduction in serum TNF- α level was observed in treated group during the muscle phase (58.4%) while in the intestinal phase was 50%. The ultrastructural study revealed degenerative effects on both adults and larvae in addition to obvious improvement of the histopathological changes in the small intestine and muscles. We concluded that these herbal extracts especially can be considered a practical and successful alternative for the treatment of trichinellosis.
旋毛虫病是一种再度出现的人畜共患病,自许多国家报告出现人类疫情以来,已成为一个公共卫生问题。传统疗法除了会产生耐药性外,还有许多不良反应。因此,有必要寻找有效的天然替代疗法。本研究旨在评估[提取物名称1]和[提取物名称2]与阿苯达唑(一种治疗旋毛虫病的传统疗法)相比的潜在治疗效果。将60只小鼠分为五组(每组12只):未感染对照组、感染对照组、阿苯达唑和泼尼松龙联合治疗组、[提取物名称1]治疗组和[提取物名称2]治疗组。分别在感染后第7天和第35天对小鼠进行处死,以研究肠道期和肌肉期的情况。除了使用透射电子显微镜进行超微结构评估外,还通过寄生虫学、组织病理学、免疫组织化学、生物化学研究来评估所用制剂的疗效。在[提取物名称1]和[提取物名称2]治疗组中,观察到成虫和幼虫的平均数量显著减少,分别为(64.5%,50.8%)和(68%,54.6%)。此外,两种提取物对TGF-β1均显示出中等程度的细胞质反应性,分别为(69.3%和67.8%)。在肌肉期,[提取物名称1]治疗组血清TNF-α水平下降最为明显(58.4%),而在肠道期为50%。超微结构研究显示,成虫和幼虫均有退行性变化,同时小肠和肌肉的组织病理学变化有明显改善。我们得出结论,这些草药提取物,尤其是[提取物名称1],可被视为治疗旋毛虫病的一种实用且成功的替代疗法。